Suppr超能文献

牛肝补充剂标签标注实践及符合美国法规情况。

Bovine Liver Supplement Labeling Practices and Compliance With U.S. Regulations.

机构信息

Schmid College of Science and Technology, Food Science Program, Chapman University, One University Drive, Orange, CA, USA.

出版信息

J Diet Suppl. 2022;19(1):4-19. doi: 10.1080/19390211.2020.1834048. Epub 2020 Nov 5.

Abstract

Bovine liver supplements are sought after by consumers due to their nutrient-dense profile and high protein content. However, there is a lack of information regarding bovine liver supplement labeling practices. The objective of this study was to assess labeling practices and compliance with U.S. regulatory standards among commercially sold bovine liver supplements. The product labels for 49 bovine liver supplements were examined for required information, including a statement of identity; net quantity of contents; "Supplement Facts" label; ingredient statement; and name and place of business of manufacturer, packer, or distributor with domestic address or telephone number. Any claims made on the supplement labels were also reviewed for compliance. Overall, 59% of the products had at least one instance of noncompliance with U.S. labeling regulations. The main categories of noncompliance were missing a domestic mailing address or phone number (39% of products), noncompliant nutrient content claim (31% of products), and missing/noncompliant disclaimer for a nutritional support statement (6% of products). The lack of a mailing address or phone number is problematic because it prevents consumers from being able to report serious adverse events to the manufacturer. The majority (85%) of the nutrient content observed on product labels was found to be noncompliant. Noncompliant nutrient content claims are a major concern for consumers who rely on these claims to assess the nutritional benefits of a product. Overall, the results of this study revealed a lack of labeling compliance in bovine liver supplements, indicating a need for increased awareness and monitoring.

摘要

牛肝补充剂因其营养丰富、蛋白质含量高而受到消费者的追捧。然而,关于牛肝补充剂标签的信息却很少。本研究旨在评估商业销售的牛肝补充剂的标签做法和合规性,以符合美国监管标准。对 49 种牛肝补充剂的产品标签进行了检查,以检查必需信息,包括身份声明、内容净量、“补充事实”标签、成分声明以及制造商、包装商或分销商的名称和地址,有国内地址或电话号码。还审查了补充标签上的任何声称是否合规。总体而言,59%的产品至少有一次不符合美国标签法规。主要的不合规类别包括缺少国内邮寄地址或电话号码(39%的产品)、营养成分声称不合规(31%的产品)以及缺少/不合规的营养支持声明免责声明(6%的产品)。缺少邮寄地址或电话号码是有问题的,因为它使消费者无法向制造商报告严重的不良事件。在产品标签上观察到的大多数(85%)营养成分含量被发现不合规。对于依赖这些声称来评估产品营养价值的消费者来说,不合规的营养成分声称是一个主要问题。总体而言,这项研究的结果显示,牛肝补充剂的标签合规性存在不足,这表明需要提高认识和加强监管。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验